Ionis Pharmaceuticals, Inc.
MODULATION OF TRANSTHYRETIN EXPRESSION
Last updated:
Abstract:
Provided herein are methods, compounds, and compositions for reducing expression of transthyretin mRNA and protein in an animal. Such methods, compounds, and compositions are useful to treat, prevent, delay, or ameliorate transthyretin amyloidosis, or a symptom thereof.
Status:
Application
Type:
Utility
Filling date:
1 Jun 2020
Issue date:
1 Apr 2021